A decade ago, when TAVR was first cleared by the FDA, surgeons had concern about losing business. But unexpectedly, TAVR has helped also gain heart surgery cases. 

Twenty-three percent of cardiologists have a net worth of more than $5 million, No. 5 among all specialties, according to a new report. A majority of cardiologists also said they have had no significant financial losses in the last year.

To avoid a potential shortage, FDA officials have said the medications can be sold to patients on a temporary basis. 

An international team of researchers, led by specialists from Cleveland Clinic, found that DAPT was consistently linked to a greater risk of major or life-threatening bleeding events. 

The American College of Cardiology has developed a helpful calculator that allows cardiologists and practice managers to estimate just how much the proposed 2023 MPFS could impact their practice.

The newly cleared device works like a traditional scale, but it captures more data than just the user's weight.